,18 Our study demonstrated that VSTM2A positively correlated with CD8+ T cell infiltration and antagonized the PD-L1/PD-1 inhibitory signal; therefore, administration of VSTM2A would inhibit CRC tumor cell growth directly while favoring lymphocyte tumor infiltration and activation. The gene discussed is PDCD1; the disease is neoplasm.